WEED:CC News and Press, Canopy Growth Corporation From 05/20/22

Canopy Growth Kicks Off Summer Long Weekends with Exciting New Product Line-Up Canada NewsWire Canadian cannabis market leader introduces new offerings across its house of brands – 7ACRES, Ace Valley, Deep Space and Doja SMITHS FALLS, ON , May ...

Stocks fell again on Thursday, putting the S&P 500 to the brink of a bear market, as investors continued to dump equities on fears Federal Reserve rate hikes to fight rapid inflation would tip the economy into a recession. The Dow Jones Industrials lost 256.16 points, or 3.6%, to st...

Canopy Growth Announces Plan to Acquire Jetty Extracts Canada NewsWire Broadens Canopy Growth's Portfolio of Premium Brands with Significant Opportunities to Scale Across North America SMITHS FALLS, ON and OAKLAND, Calif. , May 18, 2022 /CNW/ ...

Canopy Growth to Report Fourth Quarter and Fiscal Year 2022 Financial Results on May 27, 2022 Canada NewsWire SMITHS FALLS, ON , May 13, 2022 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its f...

Many of the TSX’s growth stocks have fallen by the wayside due to rising inflation and slowing economic growth. BlackBerry (TSX:BB) (NYSE:BB) , Canopy Growth (TSX:WEED) (NYSE:CGC), and Martinrea International (TSX:MRE) traded above $11 on year-end 2021...

THCV, or tetrahydrocannabivarin may have the potential to help with energy, focus/attention, and eve appetite, weight/BMI. In fact, in a study of 900 adults aged 21 and older in the U.S., InMed Pharmaceuticals Inc.’s (NASDAQ: INM) subsidiary, BayMedica, will be providing rare can...

Cannabinoids, such as cannabidivarin (CBDV) could be a therapeutic game-changer. In fact, according to InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Eric Hsu, SVP, Pre-Clinical Research and Development for InMed commented; “Cannabinoids hold tremendous therapeutic potential t...

Canopy Growth Announces Cost Reduction Actions to Accelerate Path to Profitability Canada NewsWire Strategic adjustments are expected to generate savings of $100 – $150 million within 12 – 18 months SMITHS FALLS, ON , April 26, 2...

Cannabinoids, such as cannabidivarin (CBDV) may be rare, but may also have exciting potential. In fact, according to InMed Pharmaceuticals Inc. (NASDAQ: INM), “CBDV is one of the most studied rare cannabinoids and has been the subject of research in autism, epilepsy, acne, alopec...

At the moment, CBN, or cannabinol is soaring in popularity. That could be significant news for companies, like Xebra Brands (CSE: XBRA) (OTCQB: XBRAF), which is launching one of the only beverages in Canada with CBN, Vicious Citrus. According to Benzinga.com, “Studies have shown ...